financetom
Business
financetom
/
Business
/
Nvidia, Microsoft hit with patent lawsuit over AI computing technology
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nvidia, Microsoft hit with patent lawsuit over AI computing technology
Sep 6, 2024 3:34 AM

Sept 5 (Reuters) - Artificial intelligence computing

giants Nvidia ( NVDA ) and Microsoft ( MSFT ) were sued in U.S.

court on Thursday for allegedly stealing a small Texas company's

data processor technology to help fuel development of AI

products.

Plaintiff Xockets accused Nvidia ( NVDA ) and Microsoft ( MSFT ) of "rampant"

patent infringement in the lawsuit, filed in Waco, Texas,

federal court.

Xockets also said the companies violated antitrust law by

conspiring with each other and with patent risk management

company RPX to fix and drive down the price of Xockets'

technology.

"Nvidia ( NVDA ) and Microsoft ( MSFT ) are abusing their dominance and market

power in AI in an attempt to pay little or nothing for the

innovations of others that are used in their products," Xockets

board member Robert Cote said in a statement.

Nvidia ( NVDA ) declined to comment. Microsoft ( MSFT ) and RPX, which is also

a defendant, did not immediately respond to requests for

comment.

Microsoft ( MSFT ) has invested billions into a partnership with

ChatGPT maker OpenAI, which has become the face of generative

AI. Nvidia's ( NVDA ) equipment is used in data centers that help develop

and run AI systems.

Xockets, founded in 2012, said its inventions for "data

processing units," or DPUs, are essential elements in some of

Nvidia ( NVDA ) and Microsoft's ( MSFT ) systems.

It said its technology allows computer systems to offload

and accelerate some tasks that would otherwise overburden server

processors.

The lawsuit said Xockets sought to license its technology to

Nvidia ( NVDA ) and Microsoft ( MSFT ), but the companies formed a pact to channel

any licensing negotiations through RPX.

Xockets said it was seeking unspecified triple damages and a

court order that would block the sale of products that allegedly

contain patent-infringing technology.

The case is Xockets Inc v Nvidia ( NVDA ), Microsoft ( MSFT ) and RPX, U.S.

District Court for the Western District of Texas, No.

6:24-cv-00453-ADA.

For Xockets: Jamie McDole of Winstead; Jason Sheasby of

Irell & Manella; and Max Ciccarelli of Ciccarelli Law Firm

For defendants: No appearances yet

Read more:

Nvidia ( NVDA ) did not receive a US Justice Department subpoena,

spokesperson says

US sets stage for antitrust probes into Microsoft ( MSFT ), OpenAI

and Nvidia ( NVDA )

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved